Author Topic: Protein in immune system triggers brain stem cells to mature into myelin-repairing oligodendrocytes  (Read 96 times)

0 Members and 0 Guests are viewing this topic.

Offline agate

  • Administrator
  • *****
  • Posts: 8568
  • MS diagnosed 1980
  • Location: Pacific Northwest
Yet another "breakthrough" but you never know--one of these studies just might be significant and might help to solve the problems of MS.

From Medical News Today, March 16, 2017:

Quote
Researchers make major brain repair discovery in fight against multiple sclerosis



Queen's University Belfast scientists have discovered that specific cells from the immune system are key players in brain repair - a fundamental breakthrough that could revolutionise the treatment of debilitating neurological disorders such as multiple sclerosis (MS).

The research study, led by Dr Yvonne Dombrowski and Dr Denise Fitzgerald at the Wellcome-Wolfson Institute for Experimental Medicine at Queen's University Belfast, is being hailed as a landmark study in unravelling the mysteries of how the brain repairs damage. This is crucial in the fight against MS, which affects 2.3 million people world-wide and over 4,500 people in Northern Ireland.

...

Until now, medical treatment could limit relapses but could not reverse the damage already done by the condition. The exciting aspect of this new research is that the team have uncovered beneficial effects of immune cells in myelin repair that have potential to reverse myelin damage. The study was an international collaboration including experts in Cambridge, San Francisco, Edinburgh, Maynooth and Nice.


The research breakthrough, which has been published in Nature Neuroscience, shows that a protein made by certain cells within the immune system triggers the brain's stem cells to mature into oligodendrocytes that repair myelin.

The discovery means that researchers can now use this new knowledge to develop medicines which will boost these particular cells and develop an entirely new class of treatments for the future.

Speaking about the importance of the new research, Dr Dombrowski, who is the lead author of the report, explained: "At Queen's we are taking a unique and fresh approach to uncover how the immune system drives brain repair. This knowledge is essential to designing future treatments that tackle neurological diseases, such as MS, in a new way - repairing damage rather than only reducing attacks. In the future, combining these approaches will deliver better outcomes for patients."

Senior author of the study, Dr Denise Fitzgerald from Queen's, experienced a condition similar to MS called transverse myelitis when she was 21 and had to learn to walk again.

Commenting on the findings, Dr Fitzgerald said: "This pioneering research, led by our team at Queen's, is an exciting collaboration of top scientists from different disciplines at Cambridge, San Francisco, Edinburgh, Maynooth and Nice. It is by bringing together these experts from immunology, neuroscience and stem cell biology that we have been able to make this landmark discovery.

"This is an important step forward in understanding how the brain and spinal cord is naturally repaired and opens up new therapeutic potential for myelin regeneration in patients. We continue to work together to advance knowledge and push the boundaries of scientific knowledge for the benefits of patients and society, in a bid to change lives for the better, across the globe."

Dr Sorrel Bickley, Head of Biomedical Research at the MS Society, said: "MS is an unpredictable and challenging condition, and we are committed to driving forward research to find effective treatments for everyone. This exciting study gives us an important understanding of how myelin repair can be promoted, which could open up new areas for treatment development. We welcome this international collaboration led by Northern Ireland, where rates of MS are amongst the highest in the world."

This work was supported by a number of funders including the BBSRC, Wellcome Trust, Leverhulme Trust and the UK MS Society.

Article: Regulatory T cells promote myelin regeneration in the central nervous system, Yvonne Dombrowski,   Thomas O'Hagan,   Marie Dittmer,   Rosana Penalva,   Sonia R Mayoral, Peter Bankhead,   Samara Fleville,   George Eleftheriadis,   Chao Zhao,   Michelle Naughton, Rachel Hassan,   Jill Moffat,   John Falconer,   Amanda Boyd,   Peter Hamilton, Ingrid V Allen, Adrien Kissenpfennig,   Paul N Moynagh,   Emma Evergren,   Bernard Perbal, Anna C Williams, Rebecca J Ingram,   Jonah R Chan,   Robin J M Franklin   & Denise C Fitzgerald, Nature Neuroscience, doi: 10.1038/nn.4528, published online 13 March 2017.


Rate this article
Public / Patient
5 based on 1 rating
Follow on TwitterTweet
Follow on Facebook11
Follow on Google+0
Follow on Linkedin0
Share via Pinterest0
0email
References
Additional information
Citations
Source: Queen's University, Belfast








« Last Edit: March 16, 2017, 03:51:48 pm by agate »
MS Speaks--online for 13 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010.

 

Related Topics

  Subject / Started by Replies Last post
0 Replies
56 Views
Last post January 31, 2017, 03:13:29 pm
by agate
0 Replies
39 Views
Last post September 08, 2018, 04:48:40 pm
by agate
0 Replies
23 Views
Last post April 19, 2019, 02:37:42 pm
by agate
0 Replies
41 Views
Last post August 15, 2019, 09:21:51 pm
by agate
0 Replies
15 Views
Last post July 10, 2020, 09:07:55 pm
by agate